ArticleBMC gastroenterology2024

Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma.

Nobukazu Hokamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.